<DOC>
	<DOCNO>NCT02390037</DOCNO>
	<brief_summary>The objective study assess incidence safety outcomes patient treat Pipeline™ Flex embolization device Shield Technology™ .</brief_summary>
	<brief_title>Pipeline™ Flex Embolization Device With Shield Technology™ Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<criteria>1 . Subject provide write informed consent use IRB/ECapproved consent form agree comply protocol requirement . 2 . Age 1880 year . 3 . Subject already select flow diversion therapy appropriate treatment . 4 . Subject unruptured target intracranial aneurysm ( IA ) . 5 . Subject target IA locate anterior posterior circulation . 1 . Major surgery past 30 day . 2 . Any known contraindication treatment Pipeline™ Flex embolization device Shield Technology™ per Instructions Use . 3 . Pregnant breastfeed woman woman wish become pregnant length study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>